Read More Pharma Industry News Will NASP transform gout care in 2026? Sobi’s biologic therapy heads for FDA decision Sobi’s NASP for uncontrolled gout advances to FDA review with June 2026 PDUFA date. Find out how this novel therapy could reshape gout treatment. byPallavi MadhirajuSeptember 10, 2025